ABSTRACT: In the three year period of 1982 to 1985, 152 patients with intracranial vascular malformations were referred to the Bicetre Hospital in Paris, France and the Toronto Western Hospital in Canada. Sixty-six patients with cerebral vascular malformations and 48 patients with dural vascular malformations underwent endovascular treatment. In 8 patients surgery was performed in combination with the embolization procedure. Detailed analysis of the angio-architecture of the vascular malformation reveals certain characteristics which may be of value in predicting the clinical outcome. Comprehensive data analysis and long term follow-up is necessary to assess the role of embolization in the treatment of intracranial vascular malformations. RESUME: Neuroangiographie chirurgicale des malformations vasculaires intracraniennes Pendant une periode de trois ans, soit de 1982 a 1985, 152 patients porteurs de malformations vasculaires intracraniennes ont 6t6 referes a I'Hopital Bicetre de Paris, France et au "Toronto Western Hospital" de Toronto, Canada. Soixante-six patients porteurs de malformations vasculaires au niveau de la dure-mere ont subi un traitement endovasculaire. Chez 8 patients, on a eu recours a la chirurgie associee a l'embolisation. Une etude detaillee de l'architecture des vaisseaux constituant ces malformations r6vele certaines caracteristiques qui peuvent etre utiles pour predire le resultat clinique. Une analyse de l'ensemble des donnees et un suivi a long terme sont necessaires pour evaluer le role de l'embolisation dans le traitement des malformations vasculaires intracraniennes.
The treatment of cerebral vascular malformations has become multi-disciplinary. In addition to surgery, radiation therapy and embolization have become accepted treatment methods over the past 5 years.
1 ' 2 ' 3,4 ' 56 ' 7 Supraselective angiography of intracranial vascular malformations has added significant information with regard to the nidus architecture and associated anomalies . 8 The results of endovascular treatment of 114 patients with intracranial vascular malformations treated in the past three years at the Bicetre Hospital in Paris and in the past eighteen months at the Toronto Western Hospital were reviewed.
Special attention was directed towards analysis of the angioarchitecture of the nidus of the lesions, as well as to the venous outflow characteristics and whenever possible these were correlated with the clinical symptomatology.
MATERIALS AND METHODS
One hundred and fifty-two patients were referred to the authors for consultation and possible treatment of intracranial vascular malformations (125 to Bicetre Hospital and 27 to Toronto Western Hospital).
A detailed record was kept for each patient, including clinical information, previous treatments, topographic information by means of CT and MRI scans, angiographic analysis of feeding vessels, nidus architecture and venous drainage characteristics as well as associated arterial and venous anomalies.
Thirty-eight patients with cerebral arteriovenous malformations (AVM) were not accepted for endovascular treatment because their angiographic characteristics were, in the opinion of the authors, felt to be unfavourable for embolization therapy. Patients with vascular malformations which were supplied by multiple normal or small sized vessels and associated with slow or only slightly increased flow, and in whom there was no history of previous hemorrhage, were not accepted for treatment. All of the patients with dural vascular malformations (D-AVM) were accepted for treatment.
Embolic agents used for treatment varied according to the specific clinical situation. For the treatment of dural arteriovenous malformations a combination of small sized particles (PV A, 160-250 microns) and liquid tissue adhesive (Isobutyl-2-cyanoacrylate, IBCA) was usually used, while for the treatment of cerebral AVM's invariably tissue adhesive was used.
Follow-up angiography and CT scans were obtained on all patients immediately following the embolization procedure and at a one year interval or whenever the clinical situation indicated.
Brain AVM's
Ofthe 104 patients referred for consultation, 66 patients with brain AVM's were treated by embolization in 128 sessions. The presenting symptoms were hemorrhage in 25 patients, seizures only in 21 patients, and a combination of progressive neurological deficit, seizures and headaches in 20 patients. The location ofthe brain AVM's was pure cortical in 31 patients, corticalventricular in 25 patients, basal ganglia and thalamus in four patients, posterior fossa in three patients, and three patients had a vein of Galen ectasia.
The presenting clinical symptoms improved following embolization in 35 patients. Follow-up angiograms demonstrated 75% obliteration ofthe lesion in 24 patients (Figure l)and 100% obliteration in eight patients ( Figure 2 ). In 13 patients a complication occurred related to the endovascular treatment. A transient neurological deficit occurred in nine patients (13.5%) and a permanent deficit occurred in three patients (4.5%). One patient died following inadvertent inflation of the calibrated leak balloon in a normal perforating branch of the basilar artery which lead to rupture of this vessel with hemorrhage and death. Six patients underwent surgery following the embolization procedure, with resultant partial removal of the AVM in two patients and complete removal in four patients. In a three year follow-up, rebleeding occurred in two patients, in whom the embolization had incompletely obliterated the AVM.
Dural AVM's
All of the 48 patients who were referred for consultation were accepted for treatment. The location of the lesion was anterior cranial fossa in one patient, orbit in one, sphenoid wing in two, parasellarin 18, tentorial in five, lateral sinus and torcular in 19 and foramen magnum in two. Cortical venous drainage was noted in 20 patients. The clinical presentation of dural vascular malformations was recently reviewed by the authors. 9 Complete obliteration of the AVM as determined by angiography was achieved in 16 patients. Symptoms were relieved following embolization in 44 patients. A transient neurological deficit (cranial nerve palsy) occurred in two patients (4%) but no permanent deficit occurred. In three patients endovascular treatment was supplemented by surgery in order to achieve complete obliteration of the lesion. Analysis of the patients with dural AVM's has shown that the presence of cortical venous drainage (Figure 3 ) represents an absolute indication for aggressive treatment. 9 These lesions tend to occur along the floor of the anterior cranial fossa as well as the tentorium, and frequently present with intracerebral, subarachnoid or subdural hemorrhage. Therefore these lesions must be completely eliminated, either by embolization alone or in combination with surgery. Treatment of dural AVM's without cortical venous drainage can be made much less aggressive, and should be based on disability caused by the clinical symptoms and natural history of the lesion balanced against the risks of treatment.
The topography of brain AVM's is usually well shown by means of MRI and CT scans.
10 " High quality selective angiography is required to make therapeutic decisions. Note should be made of associated arterial anomalies such as aneurysms and ectasias; the nidus architecture such as a vascular network, arteriovenous shunt, intralesional aneurysms or venous ectasias, as well as the venous outflow characteristics of the vascular malformation should be carefully studied.
Aneurysms associated with brain AVM's that are not arising from the parent vessel feeding the AVM should probably be treated by surgery prior to embolization of the AVM. 12 Intralesional aneurysms need to be treated at the same time as the AVM and therefore deposition of embolic material in the nidus should include the intralesional aneurysm. Aneurysms arising from the feeding artery proximal to the AVM often regress in size following the treatment of the AVM. (Figure 4) 
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Figure 3 -Dural AVM with cortical venous drainage. 53-year-old female with temporal lobe seizures and a bruit. A) Distal external carotid angiogram, lateral view, early arterial phase. B) Late phase. The nidus of the dural A VM (open arrow) is seen adjacent to the transverse sinus and is fed mainly by the petrosquamosal branch of the middle meningeal artery (arrow) and drains towards the cortical venous system of the brain, (curved arrows)
Dural AVM's with cortical venous drainage may present with clinical symptoms similar to brain AVM's. Since the feeding arteries and the nidus are obviously in different anatomical locations, the only common feature between these conditions is their venous drainage characteristics.
It therefore appears reasonable to suspect that the clinical symptoms of brain AVM's may be related to the influence of their venous drainage characteristics.
Venous outflow anomalies in patients with vein of Galen ectasia have been recently reviewed by the authors l3 and appear to indicate a strong relationship between the clinical symptoms and the site of venous obstruction. The presence of intralesional venous pouches or venous kinking (Figure 5 ), may represent an increased risk for hemorrhage, and only long term follow-up will determine whether the disappearance of these venous anomalies following partial embolization will result in decreased risk of hemorrhage. (Figure 6 )
The Paris-Toronto experience is unique in that it consists of a large number of patients treated by embolization alone. It will therefore represent a valuable series for comparison with other treatments such as surgery alone or in combination with embolization and/or radiation.
B
Figure lead to a better understanding of the pathophysiological basis of the symptoms and natural history, and should lead to improved treatment. Long term follow-up will be necessary to accurately determine the results of endovasculartreatment especially in patients in whom the lesion has been only partially obliterated. Early indications are that endovascular treatment, if performed by experienced teams, represents a relatively safe and effective treatment, to be seriously considered either alone or in combination with surgery in the treatment strategy of patients with intracranial AVM's.
